Medivation, Inc. (NASDAQ:MDVN)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies.

Recs

0
Player Avatar baselineace (< 20) Submitted: 12/30/2011 3:48:02 PM : Underperform Start Price: $38.72 MDVN Score: -59.76

Overextended

Report this Post Reply

Featured Broker Partners


Advertisement